A detailed history of Strs Ohio transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Strs Ohio holds 12,800 shares of GLSI stock, worth $160,768. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,800
Previous 4,800 166.67%
Holding current value
$160,768
Previous $82,000 123.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$12.99 - $17.58 $103,920 - $140,640
8,000 Added 166.67%
12,800 $183,000
Q2 2024

Aug 05, 2024

BUY
$12.07 - $19.04 $57,936 - $91,392
4,800 New
4,800 $82,000
Q2 2022

Jul 25, 2022

SELL
$7.14 - $20.36 $6,426 - $18,324
-900 Closed
0 $0
Q2 2021

Jul 26, 2021

BUY
$31.24 - $53.6 $28,116 - $48,240
900 New
900 $40,000

Others Institutions Holding GLSI

About Greenwich LifeSciences, Inc.


  • Ticker GLSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,848,200
  • Market Cap $161M
  • Description
  • Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...
More about GLSI
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.